Frequent p16INK4A /CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors

Junan Li, Christopher M. Weghorst, Masahiro Tsutsumi, Ming J. Poi, Thomas J. Knobloch, Bruce C. Casto, W. Scott Melvin, Ming Daw Tsai, Peter Muscarella

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The p16INK4A/CDKN2A (p16) tumor suppressor gene is known to be inactivated in up to 98% of human pancreatic cancer specimens. Chemically induced pancreatic tumors in Syrian golden hamsters have been demonstrated to share many morphological and biological similarities with human pancreatic tumors and represent a potentially suitable model for the evaluation of therapies targeting p16. The purpose of this study was to evaluate primary hamster pancreatic tumor specimens for potentially inactivating p16 alterations. Tumors were induced with N-nitroso-bis-(2-oxopropyl) amine, followed by two cycles of augmentation pressure, and were harvested on day 100. Foci of tumor cells were identified by light microscopy after staining with hematoxylin and eosin, and corresponding tumor tissues were excised for DNA extraction. The techniques of multiplex real-time PCR, direct sequencing and methylation-specific PCR were used to evaluate 30 tumor specimens for homozygous deletions, mutations and aberrant methylation of 5′ CpG islands, respectively. Homozygous deletions were identified in 11 of 30 (36.7%) specimens, mutations were identified in four of 30 (13.3%) specimens, and aberrant methylation of 5′ CpG islands was found in 14 of 30 (46.7%) specimens. The overall frequency of p16 alterations was 93.3% (28 of 30 specimens) and the majority of changes (83.3%) were noted to be secondary to methylation or homozygous deletion. The four mutations significantly impaired cyclin-dependent kinase 4 inhibitory activity, and two resulted in perturbation of the global structure of P16 protein. These findings indicate that p16 inactivation is a common event in chemically induced hamster tumors, and that this animal model is appropriate for comparative studies evaluating pancreatic cancer therapeutic strategies targeting p16.

Original languageEnglish (US)
Pages (from-to)263-268
Number of pages6
JournalCarcinogenesis
Volume25
Issue number2
DOIs
StatePublished - Feb 2004
Externally publishedYes

Fingerprint

Mesocricetus
Methylation
Neoplasms
CpG Islands
Pancreatic Neoplasms
Cricetinae
Cyclin-Dependent Kinase 4
Mutation
Sequence Deletion
Multiplex Polymerase Chain Reaction
Hematoxylin
Eosine Yellowish-(YS)
Tumor Suppressor Genes
Amines
Real-Time Polymerase Chain Reaction
Microscopy
Animal Models
Staining and Labeling
Light
Pressure

ASJC Scopus subject areas

  • Cancer Research

Cite this

Frequent p16INK4A /CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors. / Li, Junan; Weghorst, Christopher M.; Tsutsumi, Masahiro; Poi, Ming J.; Knobloch, Thomas J.; Casto, Bruce C.; Melvin, W. Scott; Tsai, Ming Daw; Muscarella, Peter.

In: Carcinogenesis, Vol. 25, No. 2, 02.2004, p. 263-268.

Research output: Contribution to journalArticle

Li, Junan ; Weghorst, Christopher M. ; Tsutsumi, Masahiro ; Poi, Ming J. ; Knobloch, Thomas J. ; Casto, Bruce C. ; Melvin, W. Scott ; Tsai, Ming Daw ; Muscarella, Peter. / Frequent p16INK4A /CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors. In: Carcinogenesis. 2004 ; Vol. 25, No. 2. pp. 263-268.
@article{f24673d6c3564d2f9a74196af6c0c791,
title = "Frequent p16INK4A /CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors",
abstract = "The p16INK4A/CDKN2A (p16) tumor suppressor gene is known to be inactivated in up to 98{\%} of human pancreatic cancer specimens. Chemically induced pancreatic tumors in Syrian golden hamsters have been demonstrated to share many morphological and biological similarities with human pancreatic tumors and represent a potentially suitable model for the evaluation of therapies targeting p16. The purpose of this study was to evaluate primary hamster pancreatic tumor specimens for potentially inactivating p16 alterations. Tumors were induced with N-nitroso-bis-(2-oxopropyl) amine, followed by two cycles of augmentation pressure, and were harvested on day 100. Foci of tumor cells were identified by light microscopy after staining with hematoxylin and eosin, and corresponding tumor tissues were excised for DNA extraction. The techniques of multiplex real-time PCR, direct sequencing and methylation-specific PCR were used to evaluate 30 tumor specimens for homozygous deletions, mutations and aberrant methylation of 5′ CpG islands, respectively. Homozygous deletions were identified in 11 of 30 (36.7{\%}) specimens, mutations were identified in four of 30 (13.3{\%}) specimens, and aberrant methylation of 5′ CpG islands was found in 14 of 30 (46.7{\%}) specimens. The overall frequency of p16 alterations was 93.3{\%} (28 of 30 specimens) and the majority of changes (83.3{\%}) were noted to be secondary to methylation or homozygous deletion. The four mutations significantly impaired cyclin-dependent kinase 4 inhibitory activity, and two resulted in perturbation of the global structure of P16 protein. These findings indicate that p16 inactivation is a common event in chemically induced hamster tumors, and that this animal model is appropriate for comparative studies evaluating pancreatic cancer therapeutic strategies targeting p16.",
author = "Junan Li and Weghorst, {Christopher M.} and Masahiro Tsutsumi and Poi, {Ming J.} and Knobloch, {Thomas J.} and Casto, {Bruce C.} and Melvin, {W. Scott} and Tsai, {Ming Daw} and Peter Muscarella",
year = "2004",
month = "2",
doi = "10.1093/carcin/bgh007",
language = "English (US)",
volume = "25",
pages = "263--268",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Frequent p16INK4A /CDKN2A alterations in chemically induced Syrian golden hamster pancreatic tumors

AU - Li, Junan

AU - Weghorst, Christopher M.

AU - Tsutsumi, Masahiro

AU - Poi, Ming J.

AU - Knobloch, Thomas J.

AU - Casto, Bruce C.

AU - Melvin, W. Scott

AU - Tsai, Ming Daw

AU - Muscarella, Peter

PY - 2004/2

Y1 - 2004/2

N2 - The p16INK4A/CDKN2A (p16) tumor suppressor gene is known to be inactivated in up to 98% of human pancreatic cancer specimens. Chemically induced pancreatic tumors in Syrian golden hamsters have been demonstrated to share many morphological and biological similarities with human pancreatic tumors and represent a potentially suitable model for the evaluation of therapies targeting p16. The purpose of this study was to evaluate primary hamster pancreatic tumor specimens for potentially inactivating p16 alterations. Tumors were induced with N-nitroso-bis-(2-oxopropyl) amine, followed by two cycles of augmentation pressure, and were harvested on day 100. Foci of tumor cells were identified by light microscopy after staining with hematoxylin and eosin, and corresponding tumor tissues were excised for DNA extraction. The techniques of multiplex real-time PCR, direct sequencing and methylation-specific PCR were used to evaluate 30 tumor specimens for homozygous deletions, mutations and aberrant methylation of 5′ CpG islands, respectively. Homozygous deletions were identified in 11 of 30 (36.7%) specimens, mutations were identified in four of 30 (13.3%) specimens, and aberrant methylation of 5′ CpG islands was found in 14 of 30 (46.7%) specimens. The overall frequency of p16 alterations was 93.3% (28 of 30 specimens) and the majority of changes (83.3%) were noted to be secondary to methylation or homozygous deletion. The four mutations significantly impaired cyclin-dependent kinase 4 inhibitory activity, and two resulted in perturbation of the global structure of P16 protein. These findings indicate that p16 inactivation is a common event in chemically induced hamster tumors, and that this animal model is appropriate for comparative studies evaluating pancreatic cancer therapeutic strategies targeting p16.

AB - The p16INK4A/CDKN2A (p16) tumor suppressor gene is known to be inactivated in up to 98% of human pancreatic cancer specimens. Chemically induced pancreatic tumors in Syrian golden hamsters have been demonstrated to share many morphological and biological similarities with human pancreatic tumors and represent a potentially suitable model for the evaluation of therapies targeting p16. The purpose of this study was to evaluate primary hamster pancreatic tumor specimens for potentially inactivating p16 alterations. Tumors were induced with N-nitroso-bis-(2-oxopropyl) amine, followed by two cycles of augmentation pressure, and were harvested on day 100. Foci of tumor cells were identified by light microscopy after staining with hematoxylin and eosin, and corresponding tumor tissues were excised for DNA extraction. The techniques of multiplex real-time PCR, direct sequencing and methylation-specific PCR were used to evaluate 30 tumor specimens for homozygous deletions, mutations and aberrant methylation of 5′ CpG islands, respectively. Homozygous deletions were identified in 11 of 30 (36.7%) specimens, mutations were identified in four of 30 (13.3%) specimens, and aberrant methylation of 5′ CpG islands was found in 14 of 30 (46.7%) specimens. The overall frequency of p16 alterations was 93.3% (28 of 30 specimens) and the majority of changes (83.3%) were noted to be secondary to methylation or homozygous deletion. The four mutations significantly impaired cyclin-dependent kinase 4 inhibitory activity, and two resulted in perturbation of the global structure of P16 protein. These findings indicate that p16 inactivation is a common event in chemically induced hamster tumors, and that this animal model is appropriate for comparative studies evaluating pancreatic cancer therapeutic strategies targeting p16.

UR - http://www.scopus.com/inward/record.url?scp=1342302487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1342302487&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgh007

DO - 10.1093/carcin/bgh007

M3 - Article

C2 - 14604895

AN - SCOPUS:1342302487

VL - 25

SP - 263

EP - 268

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 2

ER -